# US 2006/0222690 A1 · Low-concentration capsaicin patch and methods for treating neuropathic pain

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0222690 A1
- Document ID: US20060222690A1
- Status: Published application
- Kind: A1
- Application number: 11/396,161
- Filed: 2006-03-30
- Published: 2006-10-05
- Earliest claimed: 2005-03-30
- Inventors: Keith Bley
- Web page: https://patentgrep.com/patent/US20060222690A1

## CPC

- A61K 9/7069: {obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide}
- A61K 31/16: Amides, e.g. hydroxamic acids
- A61K 31/165: having aromatic rings, e.g. colchicine, atenolol, progabide
- A61L 24/0084: {containing fillers of phosphorus-containing inorganic compounds, e.g. apatite}
- A61P 25/04: Centrally acting analgesics, e.g. opioids
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Described here are patches and methods for treating neuropathic pain. In some variations, the neuropathic pain-relieving patch comprises capsaicin or a capsaicin analog, wherein the concentration of the capsaicin or capsaicin analog is less than 1% by weight, and a penetration enhancer, wherein the patch is capable of relieving neuropathic pain over a sustained period of time. The penetration enhancer may be any suitable penetration enhancer. The patches may also include oils, viscosity increasing agents, and the like. In some variations, the pain-relieving patches comprise capsaicin, or an, wherein the concentration of the capsaicin or analog is less than 1%, and a penetration enhancer, whereby delivery of capsaicin from the patch continues for at least an hour, and whereby a single use of the patch provides a therapeutic benefit for at least one month, two months, or three months. Methods for treating neuropathic pain are also described.

## Claims

### Claim 1

A neuropathic pain-relieving patch comprising:
capsaicin or a capsaicin analog, wherein the concentration of the capsaicin or capsaicin analog is less than 1% by weight; and
a penetration enhancer, wherein the patch is capable of relieving neuropathic pain for a sustained period of time.

### Claim 2 (depends on 1)

The neuropathic pain-relieving patch of claim 1 wherein the penetration enhancer is selected from the group consisting of ethers, esters, alcohols, fatty acids, terpenes, amines, and mixtures thereof.

### Claim 3 (depends on 1)

The neuropathic pain-relieving patch of claim 1 wherein the penetration enhancer is selected from the group consisting of 1-menathone, dimethyl isosorbide, caprylic alcohol, lauryl alcohol, oleyl alcohol, ethylene glycol, diethylene glycol monoethyl ether, triethylene glycol, butylene glycol, valeric acid, pelargonic acid, caproic acid, caprylic acid, lauric acid, oleic acid, isovaleric acid, isopropyl butyrate, isopropyl hexanoate, butyl acetate, methyl acetate, methyl valerate, ethyl oleate, poloxamer, d-piperitone, methylnonenoic acid, methylnonenoic alcohol, and d-pulegone, and mixtures thereof.

### Claim 4 (depends on 3)

The neuropathic pain-relieving patch of claim 3 wherein the penetration enhancer is diethylene glycol monoethyl ether.

### Claim 5 (depends on 1)

The neuropathic pain-relieving patch of claim 1 further comprising a self-adhesive matrix.

### Claim 6 (depends on 5)

The neuropathic pain-relieving patch of claim 5 wherein the self-adhesive matrix comprises an amine-resistant polysiloxane.

### Claim 7 (depends on 6)

The neuropathic pain-relieving patch of claim 6 wherein the amine resistant polysiloxane comprises a mixture of medium and high tack polysiloxane.

### Claim 8 (depends on 6)

The neuropathic pain-relieving patch of claim 6 further comprising about 0.5% to about 5% by weight of a silicone oil.

### Claim 9 (depends on 1)

The neuropathic pain-relieving patch of claim 1 further comprising a viscosity increasing agent.

### Claim 10 (depends on 9)

The neuropathic pain-relieving patch of claim 9 wherein the viscosity increasing agent is ethylcellulose, hydropropylcellulose, or mixtures thereof.

### Claim 11 (depends on 1)

The neuropathic pain-relieving patch of claim 1 further comprising a backing layer.

### Claim 12 (depends on 11)

The neuropathic pain-relieving patch of claim 11 wherein the backing layer comprises a polyester film.

### Claim 13 (depends on 11)

The neuropathic pain-relieving patch of claim 11 wherein the backing layer is about 10 to about 20 μm thick.

### Claim 14

A neuropathic pain-relieving patch comprising:
0.04% by weight or less of capsaicin or a capsaicin analog;
10-20% by weight of diethylene glycol monoethyl ether;
0-2% by weight of ethylcellulose;
0-5% by weight of silicone oil; and
58-85% by weight of a self-adhesive polysiloxane.

### Claim 15 (depends on 14)

The neuropathic pain-relieving patch of claim 14 further comprising a backing layer.

### Claim 16 (depends on 15)

The neuropathic pain-relieving patch of claim 15 wherein the backing layer comprises a polyester film

### Claim 17 (depends on 14)

The neuropathic pain-relieving patch of claim 14 wherein the backing layer is about 10 to about 20 μm thick.

### Claim 18

A neuropathic pain-relieving patch comprising:
capsaicin, or a capsaicin analog, wherein the concentration of the capsaicin or capsaicin analog is less than 1%; and
a penetration enhancer, wherein delivery of capsaicin from the patch continues for at least an hour, and wherein a single use of the patch provides a therapeutic benefit for at least one month.

### Claim 19 (depends on 18)

The neuropathic pain-relieving patch of claim 18 wherein the penetration enhancer is selected from the group consisting of ethers, esters, alcohols, fatty acids, terpenes, amines, and mixtures thereof.

### Claim 20 (depends on 18)

The neuropathic pain-relieving patch of claim 18 wherein the penetration enhancer is selected from the group consisting of 1-menathone, dimethyl isosorbide, caprylic alcohol, lauryl alcohol, oleyl alcohol, ethylene glycol, diethylene glycol monoethyl ether, triethylene glycol, butylene glycol, valeric acid, pelargonic acid, caproic acid, caprylic acid, lauric acid, oleic acid, isovaleric acid, isopropyl butyrate, isopropyl hexanoate, butyl acetate, methyl acetate, methyl valerate, ethyl oleate, poloxamer, d-piperitone, methylnonenoic acid, methylnonenoic alcohol, and d-pulegone, and mixtures thereof.

### Claim 21 (depends on 20)

The neuropathic pain-relieving patch of claim 20 wherein the penetration enhancer is diethylene glycol monoethyl ether.

### Claim 22 (depends on 18)

The neuropathic pain-relieving patch of claim 18 further comprising a self-adhesive matrix.

### Claim 23 (depends on 22)

The neuropathic pain-relieving patch of claim 22 wherein the self-adhesive matrix comprises an amine-resistant polysiloxane.

### Claim 24 (depends on 23)

The neuropathic pain-relieving patch of claim 23 wherein the amine resistant polysiloxane comprises a mixture of medium and high tack polysiloxane.

### Claim 25 (depends on 23)

The neuropathic pain-relieving patch of claim 23 further comprising about 0.5% to about 5% by weight of a silicone oil.

### Claim 26 (depends on 18)

The neuropathic pain-relieving patch of claim 18 further comprising a viscosity increasing agent.

### Claim 27 (depends on 26)

The neuropathic pain-relieving patch of claim 26 wherein the viscosity increasing agent is ethylcellulose, hydropropylcellulose, or mixtures thereof.

### Claim 28 (depends on 18)

The neuropathic pain-relieving patch of claim 18 further comprising a backing layer.

### Claim 29 (depends on 28)

The neuropathic pain-relieving patch of claim 28 wherein the backing layer comprises a polyester film.

### Claim 30 (depends on 28)

The neuropathic pain-relieving patch of claim 28 wherein the backing layer is about 10 to about 20 μm thick.

### Claim 31 (depends on 18)

The neuropathic pain-relieving patch of claim 18 wherein a single use of the patch provides a therapeutic benefit for at least two months.

### Claim 32 (depends on 18)

The neuropathic pain-relieving patch of claim 18 wherein a single use of the patch provides a therapeutic benefit for at least three months.

### Claim 33

A method for treating neuropathic pain comprising the step of dermally delivering a single administration of capsaicin or a capsaicin analog, wherein the concentration of the capsaicin or capsaicin analog is less than 1%.

### Claim 34 (depends on 33)

The method of claim 33 wherein the dermal delivery of the capsaicin or capsaicin analog provides a therapeutic benefit for at least one month.

### Claim 35 (depends on 34)

The method of claim 34 wherein the dermal delivery of the capsaicin or capsaicin analog provides a therapeutic benefit for at least two months.

### Claim 36 (depends on 34)

The method of claim 34 wherein the dermal delivery of the capsaicin or capsaicin analog provides a therapeutic benefit for at least three months.

### Claim 37 (depends on 1)

A method for treating neuropathic pain by applying the patch of claim 1 to an area of skin.

### Claim 38 (depends on 14)

A method for treating neuropathic pain by applying the patch of claim 14 to an area of skin.

### Claim 39 (depends on 18)

A method for treating neuropathic pain by applying the patch of claim 18 to an area of skin.
